<DOC>
	<DOC>NCT01521455</DOC>
	<brief_summary>The purpose of this study is to prove that HCP0910 is therapeutically equivalent to Seretide 250 Diskus when repeatedly dosed to Asthmatic patients.</brief_summary>
	<brief_title>Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients</brief_title>
	<detailed_description />
	<mesh_term>Fluticasone Propionate, Salmeterol Xinafoate Drug Combination</mesh_term>
	<criteria>age 20 ~ 75 inclusive Asthmatic diagnosis in more than 12 weeks from screening day Shows more than 12 % increase, and 200mL increase in FEV1 measure on Visit 2 Maintain controlled asthma for more than 4 weeks before screening Diagnosed as a severe asthmatic patients</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>